Skip to main content

Invitrogen's VisiGen Purchase Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Oct. 24.
 
1. Invitrogen Discloses $20M VisiGen Acquisition; Posts 15-Percent Q3 Revenue Growth (from Oct. 21)
 
2. Researchers Find Evidence for Horizontal Gene Transfer in Mammals, Reptiles (from Oct. 21)
 
3. TSP Consortium Uncovers Lung Cancer Culprits Using Genomic Approaches (from Oct. 22)
 
4. Experts Urge Global View, Focus on Reimbursement for Microarray Firms Developing MDx (from Oct. 23)
 
5. Myriad to Split Drug Development, Molecular Dx Businesses (from Oct. 20)
The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.